Medtronic plc (MDT:NYSE) closed at $102.86 on November 13, 2026, up 1.85% on the day. The stock trades 3.3% below its 52-week high of $106.33 and 40.3% above its 52-week low of $73.31. Over the past year, it gained 7.3%. Medtronic plc is part of the Health Care sector (Biotechnology: Electromedical & Electrotherapeutic Apparatus).
In 252 trading sessions since November 13, 2025, MDT closed higher on 113 days (45%). Its best day was November 4, 2026 (+6.15%) and its worst was July 14, 2026 (-5.11%). It never moved 10% or more in a single session.
Medtronic plc manufactures and sells device-based medical therapies worldwide. The company's Cardiac and Vascular Group segment offers pacemakers, implantable cardioverter defibrillators and cardiac resynchronization therapy devices, AF products, diagnostics and monitoring devices, and remote monitoring and patient-centered software; and heart valves, percutaneous coronary intervention stent products, surgical valve replacement and repair products, endovascular stent grafts, peripheral vascular intervention products, and products to treat superficial and deep venous diseases. Its Minimally Invasive Therapies Group segment provides gastrointestinal diagnostics, ablation, and interventional lung solutions; stapling, vessel sealing, and other surgical instruments; sutures; electrosurgery products; hernia mechanical devices; mesh implants; products for patient monitoring and recovery; sensors; monitors; compression and dialysis, enteral feeding, and wound care products; and operating room supplies, electrodes, needles, syringes, and sharps disposals. The company's Restorative Therapies Group segment offers products for various areas of the spine; bone graft substitutes; biologic produc...
Find more stocks like MDT with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.